The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-life use of nivolumab and pembrolizumab in four adult university teaching hospitals in Québec, Canada.
 
Nathalie Letarte
Honoraria - Lilly; Novartis Canada Pharmaceuticals Inc
Consulting or Advisory Role - Novartis Canada Pharmaceuticals Inc
 
Layal El Raichani
No Relationships to Disclose
 
Chantal Guevremont
No Relationships to Disclose
 
Nathalie Marcotte
No Relationships to Disclose
 
Ghislain Berard
Honoraria - Abbvie; Celgene; Janssen; Novartis Canada Pharmaceuticals Inc; Seagen; Teva
 
Marie-Claude Michel
No Relationships to Disclose
 
France Varin
No Relationships to Disclose
 
Elaine Pelletier
No Relationships to Disclose
 
Paul Farand
No Relationships to Disclose
 
Louise Deschênes
No Relationships to Disclose
 
Daniel Froment
Honoraria - Amgen; Lilly; Sanofi
 
Philippe Ovetchkine
No Relationships to Disclose
 
Marie-Andrée Fournier
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - Merck (Inst)
 
Raghu Rajan
No Relationships to Disclose
 
Rahima Jamal
Honoraria - Merck; Novartis Canada Pharmaceuticals Inc